search
Back to results

Effect of High Flow Nasal Cannula vs. Standard Care on Respiratory Stability in Pediatric Procedural Sedation (HiFiPPS)

Primary Purpose

Respiratory Insufficiency

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
High Flow nasal cannula
Standard respiratory care
Sponsored by
University of Freiburg
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Respiratory Insufficiency focused on measuring apnea, children, hypercarbia, procedural sedation, HFNC

Eligibility Criteria

6 Years - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Age 6 years - 18 years
  2. Undergoing pediatric non-emergency upper gastrointestinal endoscopy under sedation
  3. Informed consent/assent for enrollment by parents/legal guardians/patient

Exclusion Criteria:

  1. Congenital or acquired malformations involving the airways
  2. Patients with the history of spontaneous pneumothorax or connectives tissue diseases (Marfan syndrome, Ehlers-Danlos-Syndrome)
  3. Patients with a history of traumatic/iatrogenic air leak within the last 3 months before enrollment

Sites / Locations

  • Center for Pediatrics, Pediatric Intensive Care Unit, Procedure Room, Medical Center - University of Freiburg

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Standard care

High Flow nasal cannula

Arm Description

Standard respiratory care. Oxygen delivered via low flow nasal cannula, increase of fractions of inspired oxygen to maintain desired oxygenation as defined per protocol.

Application of humidified heated ambient air with flow rates adapted to body weight of respective subject. Incremental increase of fraction of inspired oxygen as appropriate to maintain oxygenation (defined as transcutaneous pulse oximetry above 93%).

Outcomes

Primary Outcome Measures

Respiratory instability
Number of episodes longer than 15 seconds with SpO2 < 93% and/ or pCO2 > 45 mmHg and/ or apnea (defined as cessation of airflow for > 15 seconds)

Secondary Outcome Measures

Duration of respiratory instability
Total duration of episodes longer than 15 seconds with oxygenation as measured per pulse oximetry < 93% and/or transcutaneously measured carbon dioxide partial pressure > 45 mmHg and/ or apnea (defined as cessation of airflow for > 15 seconds)
Number of interventions to regain respiratory stability
Number of interventions to reestablish respiratory stability (combined numbers of episode for jaw thrust, repositioning of the patient, repositioning of the patients head, tactile stimulation)
Need for noninvasive ventilation
Number of episodes of bag-mask-ventilation
Time of procedure in minutes
Time of procedure in minutes
Time of sedation in minutes
Time of sedation in minutes
Use of sedatives
Cumulative dose of i.v. sedatives in mg/kg bodyweight/min of procedure
Use of analgesics
Cumulative dose of i.v. analgesics in µg/kg bodyweight/min of procedure
Nausea and vomiting
Number of Episodes with nausea and/or vomiting within 24 hours after procedural sedation

Full Information

First Posted
October 9, 2016
Last Updated
July 20, 2018
Sponsor
University of Freiburg
search

1. Study Identification

Unique Protocol Identification Number
NCT02930525
Brief Title
Effect of High Flow Nasal Cannula vs. Standard Care on Respiratory Stability in Pediatric Procedural Sedation
Acronym
HiFiPPS
Official Title
Effect of High Flow Nasal Cannula vs. Standard Care on Respiratory Stability in Pediatric Procedural Sedation: A Randomized Controlled Pilot Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2018
Overall Recruitment Status
Completed
Study Start Date
September 2016 (Actual)
Primary Completion Date
December 2017 (Actual)
Study Completion Date
December 19, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Freiburg

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Procedural sedation is an established and safe intervention and is widely used in diagnostic and therapeutic procedures for pediatric patients. Nonetheless, problems of the respiratory system such as upper airway obstruction, hypoventilation and apnea are frequent adverse events. We postulate that respiratory instability is less frequent in patients high flow nasal cannula vs. standard care on respiratory stability, i.e. low flow nasal cannula, in pediatric procedural sedation. The purpose of this pilot study is to estimate the effect of HFNC (high flow nasal cannula) on the respiratory instability in children undergoing upper gastrointestinal endoscopy under pediatric procedural sedation (PPS).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Insufficiency
Keywords
apnea, children, hypercarbia, procedural sedation, HFNC

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard care
Arm Type
Active Comparator
Arm Description
Standard respiratory care. Oxygen delivered via low flow nasal cannula, increase of fractions of inspired oxygen to maintain desired oxygenation as defined per protocol.
Arm Title
High Flow nasal cannula
Arm Type
Experimental
Arm Description
Application of humidified heated ambient air with flow rates adapted to body weight of respective subject. Incremental increase of fraction of inspired oxygen as appropriate to maintain oxygenation (defined as transcutaneous pulse oximetry above 93%).
Intervention Type
Other
Intervention Name(s)
High Flow nasal cannula
Intervention Description
Application of humidified heated ambient air with flow rates adapted to body weight of respective subject. Incremental increase of fraction of inspired oxygen as appropriate to maintain oxygenation (defined as transcutaneous pulse oximetry above 93%).
Intervention Type
Other
Intervention Name(s)
Standard respiratory care
Intervention Description
Standard respiratory care. Oxygen delivered via low flow nasal cannula, increase of fractions of inspired oxygen to maintain desired oxygenation as defined per protocol.
Primary Outcome Measure Information:
Title
Respiratory instability
Description
Number of episodes longer than 15 seconds with SpO2 < 93% and/ or pCO2 > 45 mmHg and/ or apnea (defined as cessation of airflow for > 15 seconds)
Time Frame
Time frame from first applications of intravenous sedatives until finishing the intended procedure
Secondary Outcome Measure Information:
Title
Duration of respiratory instability
Description
Total duration of episodes longer than 15 seconds with oxygenation as measured per pulse oximetry < 93% and/or transcutaneously measured carbon dioxide partial pressure > 45 mmHg and/ or apnea (defined as cessation of airflow for > 15 seconds)
Time Frame
Time frame from first applications of intravenous sedatives until finishing the intended procedure
Title
Number of interventions to regain respiratory stability
Description
Number of interventions to reestablish respiratory stability (combined numbers of episode for jaw thrust, repositioning of the patient, repositioning of the patients head, tactile stimulation)
Time Frame
Time frame from first applications of intravenous sedatives until finishing the intended procedure
Title
Need for noninvasive ventilation
Description
Number of episodes of bag-mask-ventilation
Time Frame
Time frame from first applications of intravenous sedatives until finishing the intended procedure
Title
Time of procedure in minutes
Description
Time of procedure in minutes
Time Frame
Duration of the procedure for which sedation is determined. It covers the time period from first positioning of the patient to repositioning of the patient or patients extremities after completion of the procedure
Title
Time of sedation in minutes
Description
Time of sedation in minutes
Time Frame
Time frame from first applications of intravenous sedatives until finishing the intended procedure
Title
Use of sedatives
Description
Cumulative dose of i.v. sedatives in mg/kg bodyweight/min of procedure
Time Frame
Time frame from first applications of intravenous sedatives until finishing the intended procedure
Title
Use of analgesics
Description
Cumulative dose of i.v. analgesics in µg/kg bodyweight/min of procedure
Time Frame
Time frame from first applications of intravenous sedatives until finishing the intended procedure
Title
Nausea and vomiting
Description
Number of Episodes with nausea and/or vomiting within 24 hours after procedural sedation
Time Frame
24 hours after procedural sedation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 6 years - 18 years Undergoing pediatric non-emergency upper gastrointestinal endoscopy under sedation Informed consent/assent for enrollment by parents/legal guardians/patient Exclusion Criteria: Congenital or acquired malformations involving the airways Patients with the history of spontaneous pneumothorax or connectives tissue diseases (Marfan syndrome, Ehlers-Danlos-Syndrome) Patients with a history of traumatic/iatrogenic air leak within the last 3 months before enrollment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Daniel Klotz, M.D.
Organizational Affiliation
Center for Pediatrics, Dep. of Pediatric Intensive Care, Medical Center - University of Freiburg, Freiburg, Germany
Official's Role
Principal Investigator
Facility Information:
Facility Name
Center for Pediatrics, Pediatric Intensive Care Unit, Procedure Room, Medical Center - University of Freiburg
City
Freiburg
ZIP/Postal Code
79100
Country
Germany

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
16978741
Citation
Deitch K, Chudnofsky CR, Dominici P. The utility of supplemental oxygen during emergency department procedural sedation and analgesia with midazolam and fentanyl: a randomized, controlled trial. Ann Emerg Med. 2007 Jan;49(1):1-8. doi: 10.1016/j.annemergmed.2006.06.013. Epub 2006 Sep 15.
Results Reference
background
PubMed Identifier
21680059
Citation
Deitch K, Chudnofsky CR, Dominici P, Latta D, Salamanca Y. The utility of high-flow oxygen during emergency department procedural sedation and analgesia with propofol: a randomized, controlled trial. Ann Emerg Med. 2011 Oct;58(4):360-364.e3. doi: 10.1016/j.annemergmed.2011.05.018. Epub 2011 Jun 15.
Results Reference
background

Learn more about this trial

Effect of High Flow Nasal Cannula vs. Standard Care on Respiratory Stability in Pediatric Procedural Sedation

We'll reach out to this number within 24 hrs